Results for 'access'
MSL Talk: Tom Caravela, Ruchit Parikh
Market Access and the MSL Role
Market Access, Pharmaceutical Industry, MSL Strategies, Medical Affairs, Career Growth
In this episode, Tom Caravela welcomes Ruchit Parikh to discuss the critical role of market access within the pharmaceutical industry. They explore the definition and significance of market access and how it intersects with MSL interactions. Ruchit identifies common knowledge gaps and provides …
Jan 10th • 26 mins listen
MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper
The Struggle With KOL Access in Todays World
KOL access, medical affairs, AI in healthcare, hybrid model, MSL relationships
Carsten Schnatwinkel and Jeanna Cooper join Tom Caravela to discuss the evolving landscape of KOL access in medical affairs. They address challenges in securing KOL access and the role of AI and digital tools in overcoming these barriers. The conversation explores the hybrid model's significance, th…
Dec 10th • 34 mins listen
MSL Talk: Tom Caravela, Paul Ward
How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future succes
Paul Ward, Oncology MSLs, AstraZeneca, MSL Society, Covid-19 impact on MSLs
My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success. In this epi…
May 12th • 41 mins listen
MSL Talk: Tom Caravela, Jason Demuth
Best Practices and Creative Ways to Gain KOL Access During COVID-19
Provide 5 SEO Keywords separated by commas
In this episode, Tom Caravela speaks with Jason Demuth about his journey from retail pharmacy to the pharmaceutical industry. Jason shares his experiences engaging Key Opinion Leaders (KOLs) during COVID, emphasizing the strategic use of social media and email communication. The discussion expl…
Oct 13th • 31 mins listen
MSL Talk: Tom Caravela, Andrea Johnson
Difficult KOLs: How to overcome challenges, find success and gain access
Medical Science Liaisons, Key Opinion Leaders, pre-call planning, KOL relationship building, overcoming challenges
In this episode, Andrea Johnson joins Tom Caravela to delve into effective strategies for Medical Science Liaisons. They explore the value of Key Opinion Leaders (KOLs), emphasizing the importance of pre-call planning and preparation. Andrea shares techniques for building strong connections wit…
Aug 30th • 32 mins listen
Cancer Buzz Podcast
Increasing Clinical Trial Access for Blood Cancers
Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinkin…
Jun 7th • 19 mins listen
Cancer Buzz Podcast
Clinical Trial Access in Rural Areas
Clinical trials are crucial to cancer research and are often standard of care for patients with cancer, but for patients in rural areas, accessing clinical trials poses significant geographic and financial barriers. On this episode, we learn how Sanford Health harnessed its passion and creativity …
Oct 16th • 24 mins listen
Asco Daily News Podcast
Addressing the Impact of Prior Authorization on Access to Cancer Treatment
Drs. Nathan Pennell and Nancy Lin discuss emerging data on the growing problem of prior authorization and insurance denials in cancer care, their potentially harmful impact on patient outcomes, and what can be done to fix the problem.
Jun 8th • 26 mins listen
The Oncology Nursing Podcast
Nurse Innovators Increase Access to Biomarker Testing During ONS Hackathon
ONS members Meghan Coleman, DNP, CRNP, and Alison McDaniel, BSN, RN, OCN®, join Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss their Evidence-Based Quality Understanding in Pathology (EQUIP) project to solve unequal access to germline and s…
Dec 24th • 46 mins listen